Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kappos

Showing results (181-190 of 225) with videos related to

Pageof 23
Sort By:
Journal of Neurology|July 15, 2000
Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study GroupG Comi, L Kappos, M Clanet, et al.
Neurology|May 10, 2006
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disabilityD K B Li, U Held, J Petkau, et al.
Neurology|June 1, 1997
Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography studyU Roelcke, L Kappos, J Lechner-Scott, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 13, 2013
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFITG Edan, L Kappos, X Montalbán, et al.
Neurology|May 25, 2011
No influence of KIF1B on neurodegenerative markers in multiple sclerosisM H Sombekke, N Jafari, K Bendfeldt, et al.
European Journal of Neurology|December 25, 2015
The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosisÖ Yaldizli, I-K Penner, T Yonekawa, et al.
Neurology|November 15, 2006
Infusion-related hypersensitivity reactions during natalizumab treatmentJ T Phillips, P W O'Connor, E Havrdova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2007
Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging resultsJ M Nielsen, B Moraal, C H Polman, et al.
Neuroradiology|January 6, 2010
Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosisI J van den Elskamp, B Boden, V Dattola, et al.
Genes, Brain, and Behavior|February 17, 2015
Genetic associations with brain cortical thickness in multiple sclerosisT Matsushita, L Madireddy, T Sprenger, et al.
Pageof 23

Showing results (181-190 of 225) with videos related to

Sort By:
Pageof 23
Journal of Neurology|July 15, 2000
Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study GroupG Comi, L Kappos, M Clanet, et al.
Neurology|May 10, 2006
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disabilityD K B Li, U Held, J Petkau, et al.
Neurology|June 1, 1997
Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography studyU Roelcke, L Kappos, J Lechner-Scott, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 13, 2013
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFITG Edan, L Kappos, X Montalbán, et al.
Neurology|May 25, 2011
No influence of KIF1B on neurodegenerative markers in multiple sclerosisM H Sombekke, N Jafari, K Bendfeldt, et al.
European Journal of Neurology|December 25, 2015
The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosisÖ Yaldizli, I-K Penner, T Yonekawa, et al.
Neurology|November 15, 2006
Infusion-related hypersensitivity reactions during natalizumab treatmentJ T Phillips, P W O'Connor, E Havrdova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2007
Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging resultsJ M Nielsen, B Moraal, C H Polman, et al.
Neuroradiology|January 6, 2010
Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosisI J van den Elskamp, B Boden, V Dattola, et al.
Genes, Brain, and Behavior|February 17, 2015
Genetic associations with brain cortical thickness in multiple sclerosisT Matsushita, L Madireddy, T Sprenger, et al.
Pageof 23